NFKB1 and cancer: Numerous studies have shown that the oncogenic capacity of CK2 in some types of cancer is associated with the dysfunction of signaling pathways, such as the Wnt protein pathway, Hedgehog protein, the transcription factor NF-κB, JAK/STAT kinases, and PTEN/PI3K/Akt-PKB [15].